Prospective open-label study of the administration of two-percent voriconazole eye drops

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 7, 2009, Pages 3153-3155

  Al Badriyeh, Daoud ^a   Leung, Lok ^b   Roydhouse, Trent ^b   Fullinfaw, Robert ^c   Daniell, Mark ^b   Davies, Geoffrey E ^b   Stewart, Kay ^a   Kong, David C M ^a  

^a MONASH UNIVERSITY   (Australia)

^b ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS; VORICONAZOLE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; AQUEOUS HUMOR; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG ABSORPTION; DRUG PENETRATION; DRUG TOLERABILITY; EYE SURGERY; FEMALE; HUMAN; KERATOMYCOSIS; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; AQUEOUS HUMOR; FEMALE; HUMANS; KERATITIS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; PYRIMIDINES; TRIAZOLES;

EID: 67649950658     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01700-08     Document Type: Article

References (16)

1. Al-Badriyeh, D., J. Li, L. Leung, G. Davies, R. Fullinfaw, K. Stewart, and D. Kong. Stability of voriconazole eye drops for off-label use in the management of ophthalmic fungal infections. Am. J. Health Syst. Pharm., in press.
2. Bhartiya, P., M. Daniell, M. Constantinou, F. M. Islam, and H. R. Taylor. 2007. Fungal keratitis in Melbourne. Clin. Exp. Ophthalmol. 35:124-130.
3. Breit, S. M., S. M. Hariprasad, W. F. Mieler, G. K. Shah, M. D. Mills, and M. G. Grand. 2005. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am. J. Ophthalmol. 139:135-140.
4. Clode, A., J. Davis, J. Salmon, T. M. Michau, and B. Gilger. 2006. Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses. Am. J. Vet. Res. 67:296-301.
5. Fischbarg, J. 1997. Mechanism of fluid transport across corneal endothelium and other epithelial layers: a possible explanation based on cyclic cell volume regulatory changes. Br. J. Ophthalmol. 81:85-89.
6. Gao, H., M. Pennesi, K. Shah, X. Qiao, S. M. Hariprasad, W. F. Mieler, S. M. Wu, and E. R. Holz. 2003. Safety of intravitreal voriconazole: electro-retinographic and histopathologic studies. Trans. Am. Ophthalmol. Soc. 101:183-189.
7. How, T. H., W. Y. Loo, E. W. Chan, L. Y. Lim, E. W. Chan, P. C. Ho, and S. Y. Chan. 1998. Stability of cefazolin sodium eye drops. J. Clin. Pharm. Ther. 23:41-47.
8. Jurkunas, U. V., D. P. Langston, and K. Colby. 2007. Use of voriconazole in the treatment of fungal keratitis. Int. Ophthalmol. Clin. 47:47-59.
9. Kamal, K. S., and M. Ranabit. 2007. Essentials of ocular pharmacology and therapeutics. Anshan Pub., London, United Kingdom.
10. Klont, R. R., C. A. Eggink, A. J. Rijs, P. Wesseling, and P. E. Verweij. 2005. Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole. Clin. Infect. Dis. 40:e110-e112.
11. Lau, D. 2006. Penetration of 1% voriconazole eye drops into human aqueous and vitreous humor-a prospective, open-label study. M.Clin.Pharm. thesis. Monash University, Melbourne, Australia.
12. Lau, D., M. Fedinands, L. Leung, R. Fullinfaw, D. Kong, G. Davies, and M. Daniell. 2008. Penetration of voriconazole, 1%, eyedrops into human aqueous humor: a prospective open-label study. Arch. Ophthalmol. 126:343-346.
13. Ozbek, Z., S. Kang, J. Sivalingam, C. J. Rapuano, E. J. Cohen, and K. M. Hammersmith. 2006. Voriconazole in the management of Alternaria keratitis. Cornea 25:242-244.
14. Polizzi, A., C. Siniscalchi, A. Mastromarino, and S. C. Sacca. 2004. Effect of voriconazole on a corneal abscess caused by fusarium. ACTA Ophthalmol. Scand. 82:762-764.
15. Thiel, M. A., A. S. Zinkernagel, J. Burhenne, C. Kaufmann, and W. E. Haefeli. 2007. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis. Antimicrob. Agents Chemother. 51:239-244.
16. Vemulakonda, G. A., S. M. Hariprasad, W. F. Mieler, R. A. Prince, G. K. Shah, and R. N. Van Gelder. 2008. Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans. Arch. Ophthalmol. 126:18-22.